Baotou Dongbao Bio-Tech Co Ltd
SZSE:300239
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Baotou Dongbao Bio-Tech Co Ltd
EPS (Diluted)
Baotou Dongbao Bio-Tech Co Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Baotou Dongbao Bio-Tech Co Ltd
SZSE:300239
|
EPS (Diluted)
¥0
|
CAGR 3-Years
-21%
|
CAGR 5-Years
18%
|
CAGR 10-Years
25%
|
|
|
Shanghai Putailai New Energy Technology Co Ltd
SSE:603659
|
EPS (Diluted)
¥1
|
CAGR 3-Years
-8%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
EPS (Diluted)
¥4
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
21%
|
|
|
C
|
CNGR Advanced Material Co Ltd
SZSE:300919
|
EPS (Diluted)
¥1
|
CAGR 3-Years
-3%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Hubei Dinglong Co Ltd
SZSE:300054
|
EPS (Diluted)
¥0
|
CAGR 3-Years
23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
14%
|
|
|
Tianqi Lithium Corp
SZSE:002466
|
EPS (Diluted)
¥0
|
CAGR 3-Years
-74%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
4%
|
|
Baotou Dongbao Bio-Tech Co Ltd
Glance View
Baotou Dongbao Bio-Tech Co., Ltd. engages in the research and development, design, production, and sales of gelatin, collagen, and calcium hydrogen phosphate. The company is headquartered in Baotou, Neimenggu and currently employs 1,354 full-time employees. The company went IPO on 2011-07-06. The firm primarily provides gelatin, which is used in the manufacture of empty capsules and food additives; calcium hydrophosphate, which is used in feed additives, as well as collagen series products, which are used in foods, cosmetics, health care products. The firm distributes its products in both domestic and overseas markets, with domestic markets as its major markets.
See Also
What is Baotou Dongbao Bio-Tech Co Ltd's EPS (Diluted)?
EPS (Diluted)
0.1
CNY
Based on the financial report for Dec 31, 2025, Baotou Dongbao Bio-Tech Co Ltd's EPS (Diluted) amounts to 0.1 CNY.
What is Baotou Dongbao Bio-Tech Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
25%
Over the last year, the EPS (Diluted) growth was -31%. The average annual EPS (Diluted) growth rates for Baotou Dongbao Bio-Tech Co Ltd have been -21% over the past three years , 18% over the past five years , and 25% over the past ten years .
